Ryerson Holding Corp (RYI) director reports 347-share equity award on Form 4
Rhea-AI Filing Summary
Ryerson Holding Corp director reports equity compensation grant. A director of Ryerson Holding Corp received 347 shares of common stock on 01/01/2026 as compensation under the company’s Director Compensation Program. The filing reports the transaction as an acquisition at a price of $0 per share, reflecting a stock-based fee rather than a cash purchase. After this grant, the director beneficially owns 1,063 Ryerson common shares held directly. The award vested in full on the grant date, meaning the director’s rights to these shares were not subject to a vesting schedule.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Ryerson Holding Corp (RYI) disclose?
Ryerson Holding Corp disclosed that a director acquired 347 shares of its common stock on 01/01/2026 as equity compensation under the Director Compensation Program.
At what price were the Ryerson (RYI) shares acquired in this Form 4 filing?
The director’s 347 shares of Ryerson common stock were reported as acquired at a price of $0 per share, indicating stock-based compensation rather than a market purchase.
How many Ryerson (RYI) shares does the reporting person own after this transaction?
Following the reported transaction, the director beneficially owns 1,063 shares of Ryerson common stock, held in a direct ownership capacity.
What is the nature of the equity award reported for the Ryerson (RYI) director?
The filing explains that the 347-share grant reflects compensation in the form of equity received under Ryerson’s Director Compensation Program, and that the award vested in full on the grant date.
Is the reporting person in this Ryerson (RYI) Form 4 a director or officer?
The filing identifies the reporting person’s relationship to Ryerson Holding Corp as a Director, with the form filed by one reporting person.
Does this Ryerson (RYI) Form 4 involve derivative securities like options or warrants?
The Form 4 includes a section for derivative securities, but no derivative transactions are reported; only a non-derivative common stock grant of 347 shares is shown.